OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 9 11:45 ET

OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains

Zacks Jan 8 08:35 ET

H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsJan 8 07:34 ET · Ratings

Opko Health's Promising Pipeline: Buy Rating Backed by Innovative Trials and Strategic Collaborations

TipRanksJan 8 07:25 ET · Ratings

Express News | Merck & Compnay and OPKO Health Shares Are Trading Higher After the Companies Announced a License and Collaboration Agreement to Develop an Epstein-Barr Virus Vaccine

BenzingaJan 7 11:15 ET

OPKO Health's ModeX Launches Phase 1 EBV Vaccine Candidate Trials With Merck

MT NewswiresJan 7 11:09 ET